Baker & McKenzie Advises Abbott Laboratories in its €4.5 Billion (US$6.6 Billion) Acquisition of Solvay’s Pharmaceuticals Business
Deal Announcement
September 29, 2009
Chicago, September 29, 2009 – Baker & McKenzie is advising long-time client Abbott Laboratories in its €4.5 billion (US$6.6 billion) acquisition of Belgium-based Solvay Group’s pharmaceuticals business.
The Baker & McKenzie team included lead corporate Partner Pablo Garcia-Moreno, corporate Partner Michael DeFranco and employment benefit Partner Maura Ann McBreen and associates Ryan Gwillim and Christian Hallett, all from the Firm’s Chicago office; tax Partners Robert DeJoy and Glenn Woll from New York; employment Partner Guenther H. Heckelmann from Frankfurt; and corporate Partner Peter Leys, tax Partner Alain Huyghe and associate Ine Jordens from Brussels.